Display omitted
Lornoxicam (LRX) is a potent nonsteroidal anti-inflammatory drug (NSAID) used extensively to manage pain and inflammatory conditions. However, the drug possesses poor aqueous ...solubility (i.e., BCS class II) and a short half-life (3–4 h). Mucoadhesive buccal tablets containing LRX -loaded solid lipid nanoparticles (SLNs) were developed to enhance the drug solubility and bioavailability and achieve a controlled release pattern for a better anti-inflammatory effect. Different LRX-loaded SLNs were prepared using the hot homogenization /ultra-sonication technique and evaluated using size analysis and entrapment efficiency (EE%). Optimized LRX -loaded SLNs formulation showed particle size of 216 ± 7.4 nm, zeta potential of −27.3 ± 4.6 mV, and entrapment efficiency of 92.56 ± 2.3 %. Dried LRX-loaded SLNs alongside mucoadhesive polymers blend (PVP K30 /HPMC K15) were compressed to prepare the mucoadhesive buccal tablets. The tablets showed proper physicochemical properties, good mucoadhesive strength, long mucoadhesive time, suitable pH surface, good swelling capacity, and controlled drug release profile. Furthermore, Fourier transform-infrared (FTIR) spectroscopy, Powder X-Ray diffraction (PXRD), and Scanning electron microscopy (SEM) studies were carried out. The in vivo anti-inflammatory effect of pure LRX, market LRX and optimized mucoadhesive buccal tablet of LRX -loaded SLNs (T3) against carrageenan-induced models were evaluated. T3 showed a significant and early anti-inflammatory response after 1 and 2 h (63.62–77.84 % inhibition) as well as an extended effect after 4 h as compared to pure and market LRX. In parallel, T3 showed the best amelioration of PGE2, COX2, and TNF-α serum levels after 4 h of carrageenan injection.
•One-third of pediatric tumor patients require radiotherapy.•High pediatric radiotherapy utilization rate in a middle-income country.•Pediatric soft tissue sarcoma requires the highest radiotherapy ...utilization rate.•Palliative radiotherapy is frequently used for brainstem glioma patients.•Palliative radiotherapy is underutilized in childhood cancers.
Although the radiotherapy utilization rate (RUR) is determined for most adult cancers, it is seldom reported in childhood tumors, particularly in low- and middle-income countries (LMIC) where the majority of pediatric cancer patients reside. This study aims to investigate the real-life RUR for pediatric tumors in a large LMIC center.
The electronic files of patients treated at a single institution during 2010–2017 were reviewed and the RUR was defined as the percentage of patients who received at least one radiotherapy (RT) course from the total number of patients.
A total of 4390 out of 13,305 pediatric cancer patients received at least one RT course with a RUR of 33%. The curative, salvage, and palliative RURs were 27.8%, 2%, and 5.7%, respectively. There was a considerable variation in the RUR between various tumors, ranging from 0% in choroid plexus papilloma and other rare tumors to 100% in intracranial germinoma. Moreover, the RUR varied among different stages within each tumor type. Overall, 753 patients received 920 palliative RT courses (range 1–9) at a median dose of 30 Gy. The most commonly irradiated metastatic sites were the bone (34%) and the brain (9.8%).
This is the first analysis to provide valuable insights into the RUR for childhood tumors. Together with population-based pediatric cancer registries, this will help decipher pediatric RT needs and deficits. Additionally, the underutilization of palliative RT calls for multidisciplinary palliative care provision for pediatric cancer patients.
We report on the fine tuning of sputtered gold nanoparticles (Au NPs) with optimized diameters (7–25 nm) and distribution on the high surface area titania nanotube arrays (TNTs). The uniform coverage ...of Au NPs both outside and inside the nanotube arrays was possible by adjusting the sputtering current, as confirmed via scanning electron microscopy imaging and X‐ray diffraction analysis. Decorating the TNTs with Au NPs extended their optical activity to the visible region of the light spectrum. This red shift was attributed to the localized surface plasmon resonance (LSPR) of Au NPs as verified computationally and experimentally. The Au–TiO2 composites demonstrated 86% increase in the photocurrent compared to the bare TNTs upon their use as photoanodes for water splitting. The photoactivity was found to depend on the size of the sputtered Au NPs. The photocurrent transient measurements under light on/off conditions revealed the photostability of the Au–TiO2 nanocomposites. The Mott–Schottky analysis showed a negative shift in the flat band position of the Au–TiO2 electrodes with increased donor density compared to the bare TNTs. Moreover, the Au–TiO2 showed lower space charge capacitance and longer life time of charge carriers.
Abstract
We report on the fine tuning of sputtered gold nanoparticles (Au NPs) with optimized diameters (7–25 nm) and distribution on the high surface area titania nanotube arrays (TNTs). The uniform ...coverage of Au NPs both outside and inside the nanotube arrays was possible by adjusting the sputtering current, as confirmed via scanning electron microscopy imaging and X‐ray diffraction analysis. Decorating the TNTs with Au NPs extended their optical activity to the visible region of the light spectrum. This red shift was attributed to the localized surface plasmon resonance (LSPR) of Au NPs as verified computationally and experimentally. The Au–TiO
2
composites demonstrated 86% increase in the photocurrent compared to the bare TNTs upon their use as photoanodes for water splitting. The photoactivity was found to depend on the size of the sputtered Au NPs. The photocurrent transient measurements under light on/off conditions revealed the photostability of the Au–TiO
2
nanocomposites. The Mott–Schottky analysis showed a negative shift in the flat band position of the Au–TiO
2
electrodes with increased donor density compared to the bare TNTs. Moreover, the Au–TiO
2
showed lower space charge capacitance and longer life time of charge carriers.
PDF